Brendan Corcoran Portfolio
Invests via Valence8 US LP | Managed by Brendan Corcoran, George Lai, Colin Pan, Alejandro Goldberg, Lawrence Small, Zhenying Wu
Invests via Valence8 US LP
Managed by Brendan Corcoran, George Lai, Colin Pan, Alejandro Goldberg, Lawrence Small, Zhenying Wu
Automatically Tracked
Brendan Corcoran Profile
Brendan Corcoran has built a distinguished career at the intersection of technology and finance. His extensive experience spans various leadership roles where he has successfully driven business transformation initiatives, positioning organizations for sustainable growth. He possesses a deep understanding of capital markets, evidenced by his active participation in innovative projects that harness cutting-edge technologies to optimize financial operations. Brendan's strategic vision enables him to identify emerging opportunities within dynamic sectors while enhancing organizational efficiencies. As an influential figure in corporate leadership circles, he continues to shape industry standards through his thought leadership and commitment to operational excellence.
Brendan Corcoran has built a distinguished career at the intersection of technology and finance. His extensive experience spans various leadership roles where he has successfully driven business transformation initiatives, positioning organizations for sustainable growth. He possesses a deep understanding of capital markets, evidenced by his active participation in innovative projects that harness cutting-edge technologies to optimize financial operations. Brendan's strategic vision enables him to identify emerging opportunities within dynamic sectors while enhancing organizational efficiencies. As an influential figure in corporate leadership circles, he continues to shape industry standards through his thought leadership and commitment to operational excellence.
Investment Philosophy & Strategy
Opportunity identification thrives within Brendan Corcoran's strategic framework, where his technological acumen meets financial expertise. By integrating innovation into investment strategies, he seeks to capitalize on trends that define future markets. With a penchant for operational efficiency, decisions are informed by rigorous analysis and industry insights that shape the competitive landscape. His entrepreneurial background reinforces an adaptive approach to capital deployment, prioritizing sectors poised for transformative growth. Committed to elevating standards in corporate governance, attention is given not only to immediate outcomes but also long-term value creation across investments.
Opportunity identification thrives within Brendan Corcoran's strategic framework, where his technological acumen meets financial expertise. By integrating innovation into investment strategies, he seeks to capitalize on trends that define future markets. With a penchant for operational efficiency, decisions are informed by rigorous analysis and industry insights that shape the competitive landscape. His entrepreneurial background reinforces an adaptive approach to capital deployment, prioritizing sectors poised for transformative growth. Committed to elevating standards in corporate governance, attention is given not only to immediate outcomes but also long-term value creation across investments.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
81.17%
Gain +0.05%
Monthly
1.38%
Yearly
17.94%
Drawdown
17.78%
$301.82M
Equity
Holdings
$301.82M
Investment
$233.55M
$120.71M
Profit -$17,150.68
Realized
$52.44M
Unrealized
$68.27M
Dividends
$17.43M
Goals
Avg. 54.5% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0.05%
Profit
-$17,150.68
Win %
92%
This Week
Compared To Last Week
Gain
-0.99%
Profit
-$3M
Win %
92%
This Month
Compared to last month
Gain
0.43%
Profit
$1.3M
Win %
92%
This Year
Compared to last year
Gain
0.44%
Profit
$1.33M
Win %
92%
XLV Health Care Select Sector SPDR Fund
+2.47%
+$401,524.47 
XLP Consumer Staples Select Sector SPDR Fund
+2.39%
+$477,162.38 
EWU iShares MSCI United Kingdom ETF
+1.58%
+$89,743.5 
GDX VanEck Gold Miners ETF
+1.29%
+$66,138.12 
EFV iShares MSCI EAFE Value ETF
+0.59%
+$77,337.87 
VTV Vanguard Value ETF
+0.51%
+$76,185.73 
IQLT iShares MSCI International Quality Factor ETF
+0.47%
+$123,947.23 
QUAL iShares MSCI USA Quality Factor ETF
+0.21%
+$193,672.32 
BIL SPDR Bloomberg 1-3 Month T-Bill ETF
+0.02%
+$6,146.16 
EWY iShares MSCI South Korea ETF
-5.17%
-$124,637.17 
PWRD TCW Transform Systems ETF
-3.67%
-$205,031.4 
SMH VanEck Semiconductor ETF
-3.6%
-$425,169.33 
COPX Global X Copper Miners ETF
-2.7%
-$80,699.24 
QQQ Invesco QQQ Trust, Series 1
-1.3%
-$660,140.08 
XLU Utilities Select Sector SPDR Fund
-0.55%
-$31,778.18 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 191 | Longs Won 141/191 73% | Profit Factor 28.53 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.75M |
| Average Win $887,224.1 | Best Trade (Oct 14) $16.46M | Sharpe Ratio -36.4 |
| Average Loss -$87,682.7 | Worst Trade (Jun 29) -$867,127.13 | Z-Score 5.2 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 1w 6d | Expectancy $632,012.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,436 | 3,093 | 2,749 | 2,405 | 2,062 | 1,718 | 1,375 | 1,031 | 687 | 344 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 307,308 | $28.08M | $28.13M | - | $47,632.89 | 0.17% | +0.022% |
| COPX Global X Copper Miners ETF | 37,018 | $1.67M | $2.91M | - | $1.25M | 74.76% | -2.697% |
| EFV iShares MSCI EAFE Value ETF | 166,318 | $9.41M | $13.12M | - | $3.71M | 39.44% | +0.593% |
| EWU iShares MSCI United Kingdom ETF | 121,275 | $3.84M | $5.78M | - | $1.93M | 50.33% | +1.577% |
| EWY iShares MSCI South Korea ETF | 15,071 | $1.08M | $2.28M | - | $1.2M | 111.15% | -5.174% |
| GDX VanEck Gold Miners ETF | 61,239 | $3.2M | $5.17M | - | $1.97M | 61.5% | +1.295% |
| IQLT iShares MSCI International Quality Factor ETF | 527,435 | $20.92M | $26.29M | - | $5.37M | 25.65% | +0.474% |
| PWRD TCW Transform Systems ETF | 54,694 | $5.26M | $5.38M | - | $119,746.93 | 2.28% | -3.672% |
| QQQ Invesco QQQ Trust, Series 1 | 69,893 | $31.35M | $50.29M | - | $18.94M | 60.43% | -1.296% |
| QUAL iShares MSCI USA Quality Factor ETF | 412,060 | $70.14M | $93.29M | - | $23.15M | 33.01% | +0.208% |
| SMH VanEck Semiconductor ETF | 20,934 | $7M | $11.4M | - | $4.4M | 62.92% | -3.596% |
| VTV Vanguard Value ETF | 67,421 | $13.01M | $14.99M | - | $1.97M | 15.17% | +0.511% |
| XLP Consumer Staples Select Sector SPDR Fund | 231,632 | $18.09M | $20.41M | - | $2.32M | 12.83% | +2.394% |
| XLU Utilities Select Sector SPDR Fund | 138,166 | $5.68M | $5.73M | - | $52,709.34 | 0.93% | -0.551% |
| XLV Health Care Select Sector SPDR Fund | 93,378 | $14.82M | $16.65M | - | $1.83M | 12.35% | +2.472% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Brendan Corcoran?
The largest contributions to the portfolio's profits come from the following stocks: VanEck Semiconductor ETF - $12.18M, iShares MSCI EAFE Value ETF - $10.96M, Invesco QQQ Trust, Series 1 - $10.48M, iShares MSCI International Quality Factor ETF - $7.91M, and Vanguard Value ETF - $5.89M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: iShares Expanded Tech-Software Sector ETF - $867,127.13, Vanguard Financials ETF (primary ticker: VFH) - $549,958.87, Keros Therapeutics Inc - $338,976.25, Tyra Biosciences, Inc - $126,736.8, and Intellia Therapeutics Inc - $115,747.8. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Brendan Corcoran's portfolio generate?
The portfolio generates substantial dividend income, with a total of $17.43M earned over time. The largest contributors to dividend income include iShares MSCI EAFE Value ETF - $3.86M, iShares MSCI International Quality Factor ETF - $2.67M, SPDR Bloomberg 1-3 Month T-Bill ETF - $1.74M, iShares MSCI USA Quality Factor ETF - $1.72M, and Vanguard Value ETF - $1.45M. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Brendan Corcoran's monthly returns?
Brendan Corcoran's monthly returns show a mixed pattern. Some months are relatively calm, while others are noticeably stronger or weaker, which suggests that performance is not fully consistent over time. This points to a strategy that may offer attractive upside but can also experience uneven short-term results.
Can Brendan Corcoran's strategy be considered aggressive or moderate?
Brendan Corcoran's strategy can be described as moderate. It balances growth potential with risk management, showing a willingness to accept some volatility while still maintaining a relatively structured and diversified approach.
Should beginners follow Brendan Corcoran's strategy?
Brendan Corcoran's strategy may be suitable for beginners, but with some caution. While the overall approach is not overly complex, it still involves a certain level of risk and variability. Beginners should be prepared for occasional fluctuations and ensure they understand the strategy before trying to follow it.
2026 © Marketlog. All Rights Reserved.
